Taisho Pharmaceutical Holdings logo

Taisho Pharmaceutical Holdings

Asia, Tokyo, Japan, Tokyo

Description

Taisho Pharmaceutical Holdings is a pharmaceutical company that provides medical drugs for patients.

Investor Profile

Taisho Pharmaceutical Holdings has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Israel.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Series B (25%)
  • Series D (25%)
  • Series A (25%)
  • Series C (25%)

Country Focus

  • United States (75%)
  • Israel (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Wearables
  • Artificial Intelligence (Ai)
  • Consumer Goods
  • Machine Learning
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Taisho Pharmaceutical Holdings frequently co-invest with?

AXA Investment Managers
Europe, Ile-de-France, France, Puteaux
Co-Investments: 2
Senvest Management
North America, New York, United States, New York
Co-Investments: 2
Features Capital
North America, Vermont, United States, Norwich
Co-Investments: 3
Hikma Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 3
Aphelion Capital
North America, Colorado, United States, Littleton
Co-Investments: 3
AW
North America, Florida, United States, Miami
Co-Investments: 2
Able Partners
North America, New York, United States, New York
Co-Investments: 1
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 1
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2

What are some of recent deals done by Taisho Pharmaceutical Holdings?

Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series CApr 22, 2025
Amount Raised: $100,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series DApr 4, 2024
Amount Raised: $58,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series BNov 2, 2021
Amount Raised: $100,000,000
Moodify

Kefar Sava, HaMerkaz, Israel

Transforming the way scents are made by developing Scent AI technology & solutions for the digitization of scent design

Artificial Intelligence (AI)Consumer GoodsMachine LearningManufacturing
Series AAug 19, 2021
Amount Raised: $8,000,000

Find More Investors Like Taisho Pharmaceutical Holdings

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Taisho Pharmaceutical Holdings | Pipeseed